Nurse-Led PrEP program boosts HIV prevention in Women's clinics
NCT ID NCT05095818
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a registered nurse could help women at risk for HIV learn about and start PrEP (a daily pill that prevents HIV) during OB/GYN visits. 440 women were randomly assigned to either standard care or a nurse-led program that included counseling and lab tests. The goal was to see if the nurse-led approach increased awareness and use of PrEP.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Emtricitabine 200 mg/Tenofovir disoproxil fumarate 300 mg (PrEP)
What this could lead to
If successful, this approach could make it easier for women to access HIV prevention medication during routine OB/GYN visits.
What could go wrong
This is a completed feasibility study, not a large-scale trial. The results may not apply to all clinics or populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-EXPOSURE PROPHYLAXIS (PREP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Outpatient Center
Baltimore, Maryland, 21287, United States